Skip to main content
. 2016 Dec 24;8(7):11555–11565. doi: 10.18632/oncotarget.14135

Figure 5. KLF5 contributes to Dex-mediated drug resistance in vivo.

Figure 5

A-C. KLF5 depletion blocked Dex-induced DTX resistance in vivo. 1 × 106 HCC1806 control or KLF5 depleted cellswere injected to female nude mice subcutaneously. When the tumor size reached around 70 mm3, mice were treated with injected with 10 mg/kg DTX with or without 1mg/ml Dex. D. DTX or Dex treatment does not significantly affect body weight of nude mice.